129 results
Page 2 of 7
8-K
EX-10.1
olcxk5b 58s3en
11 Apr 23
Adaptimmune and GSK Have Agreed Terms for Transfer of PRAME and NY-ESO Target Programs back to Adaptimmune
8:08am
S-4
6kilt78bs5ip3
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.1
v6h 9o27n
20 Dec 22
Entry into a Material Definitive Agreement
4:05pm
8-K
EX-99.1
b586iekq
8 Nov 22
Adaptimmune Reports Third-Quarter Financial Results and Business Update
7:42am
8-K
EX-99.1
2np1p2uu
4 Aug 22
Adaptimmune Reports Second-Quarter Financial Results and Business Update
7:36am
8-K
EX-99.1
0y3ix
9 May 22
Adaptimmune Reports First Quarter Financial Results and Business Update
7:40am
8-K
EX-10.1
g7rsilpw 6vqm3vds
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
424B5
7wp6 byz19ulm
28 Apr 22
Prospectus supplement for primary offering
8:09am
8-K
EX-99.1
bfmzlu28cdji
14 Mar 22
Adaptimmune Reports Fourth Quarter and Full Year 2021 Financial Results and Business Update
8:06am
8-K
EX-10.01
3ksn ypooa9
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am